Thelansis’s "Postpartum Depression (PPD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postpartum Depression treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Postpartum depression (PPD) is a depressive disorder that arises within the first year after childbirth and meets criteria for major depression when symptoms persist for more than two weeks. It affects a substantial minority of new parents, with prevalence estimates varying across populations and settings. Risk factors include a prior personal or family history of mood disorder, high perinatal stress, limited social support, and complications during pregnancy or delivery. Core symptoms are persistent low mood, loss of interest or pleasure, marked anxiety, sleep and appetite disturbances, impaired concentration, and in some cases thoughts of self‑harm or harm to the infant. Diagnosis requires clinical assessment and can be aided by validated screening tools such as the Edinburgh Postnatal Depression Scale. Treatment is individualized and may include psychotherapy, antidepressant medication when indicated, and practical supports for the mother and family, with breastfeeding considerations incorporated into medication choices. Early identification and timely referral to mental health services are important to protect maternal well-being and support healthy infant development.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.
1. Key Findings and Analyst Commentary
2. Disease Context
3. Epidemiology
4. Market Size and Forecast
5. Competitive Landscape
6. Unmet Need and TPP Analysis
7. Regulatory and Reimbursement Environments (by country and payer insights)
8. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Postpartum Depression (PPD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report
Our team will get in touch with you shortly about the Postpartum Depression (PPD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report.